Literature DB >> 20223910

Longitudinal MRI shows no cerebral abnormality in chronic fatigue syndrome.

R Perrin1, K Embleton, V W Pentreath, A Jackson.   

Abstract

MRI has previously provided conflicting results when used to search for brain abnormalities in sufferers of chronic fatigue syndrome (CFS). Eighteen CFS patients and nine healthy volunteers each underwent MRI on two occasions, one year apart. The resulting images were examined for abnormalities in brain atrophy, deep white matter hyperintensities (WMH) and cerebral blood and cerebrospinal fluid (CSF) flow. Mean proportionate CSF volume was not significantly different between subject groups. All participants showed a slight increase in CSF between scans, but no significant difference was found between those with CFS and those without. Between-group comparisons of ventricular volume revealed no significant differences at study commencement and no significant change over the year. No significant inter-group differences were found for any of the cerebral blood and CSF flow parameters. Low levels of WMH were found in all participants. Objective scoring of WMH using Scheltens' scale revealed no change in summary components (prosencephalic deep white matter hyperintensities, basal ganglia hyperintensities and infratentorial hyperintensities) or in individual component variables between the baseline and 1 year follow-up scans. No abnormal patterns in rate and extent of brain atrophy, ventricle volume, white matter lesions, cerebral blood flow or aqueductal CSF flow were detected in the CFS population. These results throw open the debate into whether MRI scanning can reveal diagnostic signs of CFS and clinically questions the diagnoses of CFS made on the basis of previous research conclusions.

Entities:  

Mesh:

Year:  2010        PMID: 20223910      PMCID: PMC3473570          DOI: 10.1259/bjr/85621779

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  16 in total

1.  The Monro-Kellie hypothesis: applications in CSF volume depletion.

Authors:  B Mokri
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

2.  Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome.

Authors:  G Lange; A I Holodny; J DeLuca; H J Lee; X H Yan; J Steffener; B H Natelson
Journal:  Appl Neuropsychol       Date:  2001

3.  Dementing disorders: volumetric measurement of cerebrospinal fluid to distinguish normal from pathologic findings -- feasibility study.

Authors:  Neil A Thacker; Anoop R Varma; Deborah Bathgate; Stavros Stivaros; Julie S Snowden; David Neary; Alan Jackson
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

4.  The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer.

Authors:  S Moorey; S Greer; M Watson; C Gorman; L Rowden; R Tunmore; B Robertson; J Bliss
Journal:  Br J Psychiatry       Date:  1991-02       Impact factor: 9.319

5.  An evaluation of the effectiveness of osteopathic treatment on symptoms associated with myalgic encephalomyelitis. A preliminary report.

Authors:  R N Perrin; J Edwards; P Hartley
Journal:  J Med Eng Technol       Date:  1998 Jan-Feb

6.  A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging.

Authors:  P Scheltens; F Barkhof; D Leys; J P Pruvo; J J Nauta; P Vermersch; M Steinling; J Valk
Journal:  J Neurol Sci       Date:  1993-01       Impact factor: 3.181

7.  Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome.

Authors:  G Lange; J DeLuca; J A Maldjian; H Lee; L A Tiersky; B H Natelson
Journal:  J Neurol Sci       Date:  1999-12-01       Impact factor: 3.181

8.  Neural correlates of the chronic fatigue syndrome--an fMRI study.

Authors:  Floris P de Lange; Joke S Kalkman; Gijs Bleijenberg; Peter Hagoort; Sieberen P van der Werf; Jos W M van der Meer; Ivan Toni
Journal:  Brain       Date:  2004-07-07       Impact factor: 13.501

9.  A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.

Authors:  Dedra Buchwald; Paul R Cheney; Daniel L Peterson; Berch Henry; Susan B Wormsley; Ann Geiger; Dharam V Ablashi; S Zaki Salahuddin; CArl Saxinger; Royce Biddle; Ron Kikinis; Ferenc A Jolesz; Thomas Folks; N Balachandran; James B Peter; Robert C Gallo; Anthony L Komaroff
Journal:  Ann Intern Med       Date:  1992-01-15       Impact factor: 25.391

10.  Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome.

Authors:  M Ichise; I E Salit; S E Abbey; D G Chung; B Gray; J C Kirsh; M Freedman
Journal:  Nucl Med Commun       Date:  1992-10       Impact factor: 1.690

View more
  14 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

Review 2.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

3.  Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study.

Authors:  B K Puri; P M Jakeman; M Agour; K D R Gunatilake; K A C Fernando; A I Gurusinghe; I H Treasaden; A D Waldman; P Gishen
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

4.  Abnormal Resting-State Functional Connectivity in Patients with Chronic Fatigue Syndrome: Results of Seed and Data-Driven Analyses.

Authors:  Charles W Gay; Michael E Robinson; Song Lai; Andrew O'Shea; Jason G Craggs; Donald D Price; Roland Staud
Journal:  Brain Connect       Date:  2015-11-10

5.  The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.

Authors:  Gerwyn Morris; Michael Berk
Journal:  BMC Med       Date:  2015-04-01       Impact factor: 8.775

6.  Increase in the Regional Cerebral Blood Flow following Waon Therapy in Patients with Chronic Fatigue Syndrome: A Pilot Study.

Authors:  Takao Munemoto; Yuji Soejima; Akinori Masuda; Yoshiaki Nakabeppu; Chuwa Tei
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

7.  Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study.

Authors:  Zack Y Shan; Richard Kwiatek; Richard Burnet; Peter Del Fante; Donald R Staines; Sonya M Marshall-Gradisnik; Leighton R Barnden
Journal:  J Magn Reson Imaging       Date:  2016-04-28       Impact factor: 4.813

Review 8.  A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

Authors:  Gerwyn Morris; Michael Berk; Basant K Puri
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

Review 9.  A Molecular Neurobiological Approach to Understanding the Aetiology of Chronic Fatigue Syndrome (Myalgic Encephalomyelitis or Systemic Exertion Intolerance Disease) with Treatment Implications.

Authors:  Jean A Monro; Basant K Puri
Journal:  Mol Neurobiol       Date:  2018-02-06       Impact factor: 5.590

10.  Brain function characteristics of chronic fatigue syndrome: A task fMRI study.

Authors:  Zack Y Shan; Kevin Finegan; Sandeep Bhuta; Timothy Ireland; Donald R Staines; Sonya M Marshall-Gradisnik; Leighton R Barnden
Journal:  Neuroimage Clin       Date:  2018-04-25       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.